These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10874582)

  • 41. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P; Guan HC; Van Tol HH
    Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective.
    Seeman P; Van Tol HH
    Eur J Pharmacol; 1993 Mar; 233(1):173-4. PubMed ID: 8097160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
    J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New perspectives on biological treatment of schizophrenia.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1994; 384():102-7. PubMed ID: 7879631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart.
    Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J
    Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
    Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice.
    Gan L; Falzone TL; Zhang K; Rubinstein M; Baldessarini RJ; Tarazi FI
    J Mol Neurosci; 2004; 22(3):167-78. PubMed ID: 14997010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.
    Nakata Y; Kanahara N; Iyo M
    J Psychopharmacol; 2017 Dec; 31(12):1511-1518. PubMed ID: 28925317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine D
    Miyauchi M; Neugebauer NM; Meltzer HY
    J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association study between the dopamine D4 receptor gene and schizophrenia.
    Petronis A; Macciardi F; Athanassiades A; Paterson AD; Verga M; Meltzer HY; Cola P; Buchanan JA; Van Tol HH; Kennedy JL
    Am J Med Genet; 1995 Oct; 60(5):452-5. PubMed ID: 8546161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine D4 receptor polymorphism and schizophrenia.
    Nanko S; Hattori M; Ikeda K; Sasaki T; Kazamatsuri H; Kuwata S
    Lancet; 1993 Mar; 341(8846):689-90. PubMed ID: 8095590
    [No Abstract]   [Full Text] [Related]  

  • 60. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
    Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
    Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.